Stockscreener 앱 받기
10.29
1.25%
-0.13
시간 외 거래:
10.35
0.06
+0.58%
전일 마감가:
$10.42
열려 있는:
$10.38
하루 거래량:
7.21M
Relative Volume:
0.79
시가총액:
$12.00B
수익:
$14.33B
순이익/손실:
$-3.79B
주가수익비율:
-3.2461
EPS:
-3.17
순현금흐름:
$1.84B
1주 성능:
-0.96%
1개월 성능:
+8.09%
6개월 성능:
+24.73%
1년 성능:
-12.50%
1일 변동 폭
$10.27
$10.46
1주일 범위
$10.18
$10.52
52주 변동 폭
$6.85
$13.55
비아트리스 Stock (VTRS) Company Profile
명칭
Viatris Inc
전화
(724) 514-1465
주소
1000 MYLAN BOULEVARD, CANONSBURG
VTRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
10.29 | 12.03B | 14.33B | -3.79B | 1.84B | -3.17 |
|
ZTS
Zoetis Inc
|
145.41 | 65.38B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.10 | 44.75B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.12 | 40.97B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.78 | 22.50B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
415.34 | 19.04B | 3.08B | 1.24B | 1.07B | 25.61 |
비아트리스 Stock (VTRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-15 | 개시 | Truist | Buy |
| 2025-06-06 | 개시 | Goldman | Neutral |
| 2024-07-19 | 재개 | Jefferies | Buy |
| 2023-10-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-23 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2023-04-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2023-02-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-10 | 업그레이드 | UBS | Sell → Neutral |
| 2022-11-08 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | 재개 | Jefferies | Hold |
| 2022-06-14 | 개시 | UBS | Sell |
| 2022-05-10 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | 개시 | Citigroup | Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | 개시 | Argus | Hold |
| 2020-12-14 | 개시 | Bernstein | Mkt Perform |
모두보기
비아트리스 주식(VTRS)의 최신 뉴스
Viatris (VTRS) Backs Phage Therapy for Eye Infections Might Change The Case For Investing - simplywall.st
Is Viatris (VTRS) Stock Undervalued Right Now? - sharewise.com
Mydriasis Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia, Taejoon Pharma - Barchart.com
Collaborating to Address Antimicrobial Resistance at Viatris - ACCESS Newswire
Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections - Business Wire
What does recent volatility data suggest for Viatris Inc.July 2025 Update & Short-Term High Return Ideas - newser.com
Is Viatris Inc. (VIA) stock overpriced at current multiplesJuly 2025 Update & Reliable Entry Point Trade Alerts - Fundação Cultural do Pará
Viatris Inc. stock outlook for YEARWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Can volume confirm reversal in Viatris Inc.Portfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Will Viatris Inc. stock benefit from upcoming earnings reportsEntry Point & Advanced Technical Signal Analysis - newser.com
Will Viatris Inc. stock recover faster than peersJuly 2025 Patterns & Entry and Exit Point Strategies - newser.com
Will Viatris Inc. stock reach Wall Street targetsTrade Exit Summary & High Return Trade Opportunity Guides - newser.com
Why analysts remain bullish on Viatris Inc. stockJuly 2025 Setups & Real-Time Market Sentiment Reports - Fundação Cultural do Pará
Will Viatris Inc. stock return to pre crisis levelsAnalyst Downgrade & Low Risk Investment Opportunities - Fundação Cultural do Pará
What’s the recovery path for long term holders of Viatris Inc.Earnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Should you wait for a breakout in Viatris Inc.Insider Selling & Daily Chart Pattern Signal Reports - newser.com
Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS) - 2822news.com
Is Viatris Inc. stock a good choice for value investorsInsider Buying & Low Risk Entry Point Guides - newser.com
Viatris updates bylaws and sets 2026 annual meeting for May 15 - Investing.com Canada
What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter - The Motley Fool
Viatris updates bylaws and sets 2026 annual meeting for May 15 By Investing.com - Investing.com South Africa
비아트리스 (VTRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
0.67%
자본화:
|
볼륨(24시간):